These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37144947)

  • 21. Prostate intra-fraction motion recorded by transperineal ultrasound.
    Ballhausen H; Belka C; Li M
    Sci Data; 2024 May; 11(1):504. PubMed ID: 38755158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosimetric feasibility of stereotactic irradiation of primary prostate cancer at 5x9 Gy with a method of urethral sparing.
    Benhmida S; Beneux A; Udrescu C; Rouviere O; Horn S; Enachescu C; Lapierre A; Chapet O
    Br J Radiol; 2021 Nov; 94(1127):20210142. PubMed ID: 34283647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical application of a sub-fractionation workflow for intrafraction re-planning during prostate radiotherapy treatment on a 1.5 Tesla MR-Linac: A practical method to mitigate intrafraction motion.
    Willigenburg T; Zachiu C; Bol GH; de Groot-van Beugel EN; Lagendijk JJW; van der Voort van Zyp JRN; Raaymakers BW; de Boer JCJ
    Radiother Oncol; 2022 Nov; 176():25-30. PubMed ID: 36113777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate stereotactic body radiotherapy: quantifying intra-fraction motion and calculating margins using the new BIR geometric uncertainties in daily online IGRT recommendations.
    McNeice JM; Sanilkumar N; Alexander SE; Talbot J; Tree AC; McNair HA
    Br J Radiol; 2023 Jun; 96(1146):20220852. PubMed ID: 37001054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimation of patient-size dependent imaging dose for stereoscopic/monoscopic real-time kV image guidance in lung and prostate SBRT.
    Abeywardhana R; Spurway A; Sattarivand M
    Phys Med Biol; 2023 Apr; 68(9):. PubMed ID: 36972605
    [No Abstract]   [Full Text] [Related]  

  • 26. Dosimetric impact of intra-fraction prostate motion under a tumour-tracking system in hypofractionated robotic radiosurgery.
    Koike Y; Sumida I; Mizuno H; Shiomi H; Kurosu K; Ota S; Yoshioka Y; Suzuki O; Tamari K; Ogawa K
    PLoS One; 2018; 13(4):e0195296. PubMed ID: 29621319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isotoxic dose prescription level strategies for stereotactic liver radiotherapy: the price of dose uniformity.
    Hansen AT; Poulsen PR; Høyer M; Worm ES
    Acta Oncol; 2020 May; 59(5):558-564. PubMed ID: 31833432
    [No Abstract]   [Full Text] [Related]  

  • 29. Dosimetric impact of interfraction prostate and seminal vesicle volume changes and rotation: A post-hoc analysis of a phase III randomized trial of MRI-guided versus CT-guided stereotactic body radiotherapy.
    Ma TM; Neylon J; Casado M; Sharma S; Sheng K; Low D; Yang Y; Steinberg ML; Lamb J; Cao M; Kishan AU
    Radiother Oncol; 2022 Feb; 167():203-210. PubMed ID: 34979212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Injection of hydrogel spacer increased maximal intrafractional prostate motion in anterior and superior directions during volumetric modulated arc therapy-stereotactic body radiation therapy for prostate cancer.
    Sawayanagi S; Yamashita H; Ogita M; Takenaka R; Nozawa Y; Watanabe Y; Imae T; Abe O
    Radiat Oncol; 2022 Feb; 17(1):41. PubMed ID: 35197092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gating has a negligible impact on dose delivered in MRI-guided online adaptive radiotherapy of prostate cancer.
    Wahlstedt I; Andratschke N; Behrens CP; Ehrbar S; Gabryś HS; Schüler HG; Guckenberger M; Smith AG; Tanadini-Lang S; Tascón-Vidarte JD; Vogelius IR; van Timmeren JE
    Radiother Oncol; 2022 May; 170():205-212. PubMed ID: 35351536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Towards fast adaptive replanning by constrained reoptimization for intra-fractional non-periodic motion during robotic SBRT.
    Gerlach S; Hofmann T; Fürweger C; Schlaefer A
    Med Phys; 2023 Jul; 50(7):4613-4622. PubMed ID: 36951392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosimetric effects of the prone and supine positions on image guided localized prostate cancer radiotherapy.
    Liu B; Lerma FA; Patel S; Amin P; Feng Y; Yi BY; Yu C
    Radiother Oncol; 2008 Jul; 88(1):67-76. PubMed ID: 18207595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of intrafraction prostate motion on clinical target coverage in proton therapy: A simulation study of dosimetric differences in two delivery techniques.
    Su Z; Slopsema R; Flampouri S; Li Z
    J Appl Clin Med Phys; 2019 Oct; 20(10):67-73. PubMed ID: 31478341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reproducibility and accuracy of a target motion mitigation technique for dose-escalated prostate stereotactic body radiotherapy.
    Greco C; Stroom J; Vieira S; Mateus D; Cardoso MJ; Soares A; Pares O; Pimentel N; Louro V; Nunes B; Kociolek J; Fuks Z
    Radiother Oncol; 2021 Jul; 160():240-249. PubMed ID: 33992627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetric evaluation of image-guided radiation therapy for prostate cancer.
    Shan G; Hu W; Chen L; Price RA; Ma CC
    Med Dosim; 2021 Summer; 46(2):117-126. PubMed ID: 33020024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of HDR brachytherapy-replicating prostate radiotherapy planning for tomotherapy, cyberknife and VMAT.
    de Chavez R; Grogan G; Hug B; Howe K; Grigg A; Waterhouse D; Lane J; Glyde A; Brown E; Bydder S; Pryor D; Hargrave C; Charles PH; Hellyer J; Ebert MA
    Med Dosim; 2022 Spring; 47(1):61-69. PubMed ID: 34551879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereotactic body radiotherapy using a hydrogel spacer for localized prostate cancer: A dosimetric comparison between tomotherapy with the newly-developed tumor-tracking system and cyberknife.
    Manabe Y; Hashimoto S; Mukouyama H; Shibamoto Y
    J Appl Clin Med Phys; 2021 Oct; 22(10):66-72. PubMed ID: 34415658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adaptive SBRT by 1.5 T MR-linac for prostate cancer: On the accuracy of dose delivery in view of the prolonged session time.
    Ruggieri R; Rigo M; Naccarato S; Gurrera D; Figlia V; Mazzola R; Ricchetti F; Nicosia L; Giaj-Levra N; Cuccia F; Vitale C; Stavreva N; Pressyanov DS; Stavrev P; Pellegrini R; Alongi F
    Phys Med; 2020 Dec; 80():34-41. PubMed ID: 33091796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing feasibility of real-time ultrasound monitoring in stereotactic body radiotherapy of liver tumors.
    Zhong Y; Stephans K; Qi P; Yu N; Wong J; Xia P
    Technol Cancer Res Treat; 2013 Jun; 12(3):243-50. PubMed ID: 23369158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.